Litcius/Paper detail

Identification and characterization of <i>in silico</i>, <i>in vivo</i>, <i>in vitro</i>, and reactive metabolites of infigratinib using LC-ITMS: bioactivation pathway elucidation and <i>in silico</i> toxicity studies of its metabolites

Nasser S. Al‐Shakliah, Mohamed W. Attwa, Adnan A. Kadi, Haitham AlRabiah

2020RSC Advances34 citationsDOIOpen Access PDF

Abstract

An <italic>in silico</italic> web designer tool was utilized to guide laboratory work for infigratinib metabolism. Sixteen metabolites of infigratinib and seven reactive intermediates (three iminium ions and four 1,4 benzoquinones) were characterized using LC-ITMS.

Topics & Concepts

In vivoChemistryGlutathioneIn silicoIn vitroGlucuronidationBiochemistryMetabolismMicrosomePharmacologyEnzymeBiologyBiotechnologyGeneColorectal Cancer Treatments and StudiesPancreatic and Hepatic Oncology ResearchPeptidase Inhibition and Analysis
Identification and characterization of <i>in silico</i>, <i>in vivo</i>, <i>in vitro</i>, and reactive metabolites of infigratinib using LC-ITMS: bioactivation pathway elucidation and <i>in silico</i> toxicity studies of its metabolites | Litcius